¿¬¼ö°­ÁÂ
2024 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-14

2024 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-14
±³À°ÀÏÀÚ : 2024-06-14
±³À°Àå¼Ò : °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀǽÇ

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540  

À̸ÞÀÏ : kalc@lungca.or.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, º´¸®°ú, °¡Á¤ÀÇÇаú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í »çÀüµî·Ï ȸ¿ø: 50,000¿ø/ ºñȸ¿ø 70,000¿ø ÇöÀåµî·Ï ȸ¿ø: 60,000¿ø/ ºñȸ¿ø 80,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 10:00~10:20 9th TNM classification for lung cancer ±èÈ«°ü (¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 10:20~10:40 9th TNM classification for thymic epithelial tumor °­Ã¢Çö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 10:40~11:00 NGS Bioinformatics for clinician À±È«¼®(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 11:00~11:20 Interpretation of NGS Reports ¾çÁ¤¿í(°æ»óÀÇ´ë)

ÈÞ½Ä 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 11:20~11:40 Coffee Break ()

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 11:40~12:20 Time to optimize the first-line treatment with osimertinib for advanced EGFR-mutant NSCLC ±èŹÎ(¼­¿ïÀÇ´ë)

ÈÞ½Ä 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 12:20~12:40 Coffee Break ()

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 12:40~13:00 Updates in SBRT and combination modalities ¹ÚÁ¾¹«(°æºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 13:00~13:20 Particle therapy and new approaches to treat highrisk patients ³ëÀç¸í(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 13:20~13:40 Local ablation therapy using bronchoscopic techniques Áö¿øÁØ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 13:40~14:00 Rigid bronchoscopy for malignant airway obstruction ¹Ú¿µ½Ä(¼­¿ïÀÇ´ë)

ÈÞ½Ä 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 14:00~14:20 Coffee Break ()

±³À°½Ã°£ 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 14:20~14:35 neoadjuvant chemoimmunotherapy ¿ÀÀÎÀç(Àü³²ÀÇ´ë)

Åä·Ð 06¿ù 14ÀÏ °æÁÖ ÇÏÀÌÄÚ 3Ãþ ´ëȸÀÇ½Ç 14:35~15:20 neoadjuvant chemoimmunotherapy Panel discussion °­ÀºÁÖ(°í·ÁÀÇ´ë)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,452 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ BPEX 5Ãþ ÄÁÆÛ·±½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇÑ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,486 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä) : 2024-02-25

±³À°ÀÏÀÚ : 2024-02-25 ±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø º»°ü ÁöÇÏ 1Ãþ ±èÁ¾±â Ȧ ±³À°ÁÖÁ¦ : ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä)ÁÖÃÖ±â°ü : ¼­

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,628 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù) : 2024-05-18

±³À°ÀÏÀÚ : 2024-05-18 ±³À°Àå¼Ò : ¿Â¶óÀÎ (24½Ã°£ VOD ´çÀÏ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 1 , Á¶È¸¼ö : 8,594 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,137 , ´ñ±Û¼ö : 0